nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Sensation of foreign body—Prednisolone—multiple sclerosis	0.0339	0.0339	CcSEcCtD
Emedastine—Hyperaemia—Dexamethasone—multiple sclerosis	0.0305	0.0305	CcSEcCtD
Emedastine—Hyperaemia—Betamethasone—multiple sclerosis	0.0305	0.0305	CcSEcCtD
Emedastine—Eye pain—Fingolimod—multiple sclerosis	0.0291	0.0291	CcSEcCtD
Emedastine—Sensation of foreign body—Dexamethasone—multiple sclerosis	0.0283	0.0283	CcSEcCtD
Emedastine—Sensation of foreign body—Betamethasone—multiple sclerosis	0.0283	0.0283	CcSEcCtD
Emedastine—Conjunctival hyperaemia—Prednisolone—multiple sclerosis	0.0251	0.0251	CcSEcCtD
Emedastine—Conjunctival hyperaemia—Betamethasone—multiple sclerosis	0.021	0.021	CcSEcCtD
Emedastine—Conjunctival hyperaemia—Dexamethasone—multiple sclerosis	0.021	0.021	CcSEcCtD
Emedastine—Endophthalmitis—Dexamethasone—multiple sclerosis	0.0194	0.0194	CcSEcCtD
Emedastine—Endophthalmitis—Betamethasone—multiple sclerosis	0.0194	0.0194	CcSEcCtD
Emedastine—Sinusitis—Fingolimod—multiple sclerosis	0.019	0.019	CcSEcCtD
Emedastine—Keratitis—Prednisolone—multiple sclerosis	0.017	0.017	CcSEcCtD
Emedastine—Eye disorder—Fingolimod—multiple sclerosis	0.017	0.017	CcSEcCtD
Emedastine—Endophthalmitis—Prednisone—multiple sclerosis	0.0169	0.0169	CcSEcCtD
Emedastine—Cardiac disorder—Fingolimod—multiple sclerosis	0.0168	0.0168	CcSEcCtD
Emedastine—Mental disorder—Fingolimod—multiple sclerosis	0.0159	0.0159	CcSEcCtD
Emedastine—Vision blurred—Fingolimod—multiple sclerosis	0.0149	0.0149	CcSEcCtD
Emedastine—Keratitis—Dexamethasone—multiple sclerosis	0.0142	0.0142	CcSEcCtD
Emedastine—Keratitis—Betamethasone—multiple sclerosis	0.0142	0.0142	CcSEcCtD
Emedastine—Stinging—Prednisolone—multiple sclerosis	0.0136	0.0136	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.0134	0.0134	CcSEcCtD
Emedastine—Eye irritation—Prednisolone—multiple sclerosis	0.0129	0.0129	CcSEcCtD
Emedastine—Nervous system disorder—Fingolimod—multiple sclerosis	0.0126	0.0126	CcSEcCtD
Emedastine—Stinging—Triamcinolone—multiple sclerosis	0.0125	0.0125	CcSEcCtD
Emedastine—Skin disorder—Fingolimod—multiple sclerosis	0.0125	0.0125	CcSEcCtD
Emedastine—Stinging—Betamethasone—multiple sclerosis	0.0114	0.0114	CcSEcCtD
Emedastine—Stinging—Dexamethasone—multiple sclerosis	0.0114	0.0114	CcSEcCtD
Emedastine—Eye disorder—Cladribine—multiple sclerosis	0.00961	0.00961	CcSEcCtD
Emedastine—Cardiac disorder—Cladribine—multiple sclerosis	0.00955	0.00955	CcSEcCtD
Emedastine—Asthenia—Fingolimod—multiple sclerosis	0.00925	0.00925	CcSEcCtD
Emedastine—Pruritus—Fingolimod—multiple sclerosis	0.00912	0.00912	CcSEcCtD
Emedastine—Mental disorder—Cladribine—multiple sclerosis	0.00901	0.00901	CcSEcCtD
Emedastine—Dry eye—Betamethasone—multiple sclerosis	0.00851	0.00851	CcSEcCtD
Emedastine—Dry eye—Dexamethasone—multiple sclerosis	0.00851	0.00851	CcSEcCtD
Emedastine—Headache—Fingolimod—multiple sclerosis	0.00808	0.00808	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00757	0.00757	CcSEcCtD
Emedastine—Discomfort—Cladribine—multiple sclerosis	0.00753	0.00753	CcSEcCtD
Emedastine—Eye pain—Betamethasone—multiple sclerosis	0.00741	0.00741	CcSEcCtD
Emedastine—Eye pain—Dexamethasone—multiple sclerosis	0.00741	0.00741	CcSEcCtD
Emedastine—Nervous system disorder—Cladribine—multiple sclerosis	0.00717	0.00717	CcSEcCtD
Emedastine—Tachycardia—Cladribine—multiple sclerosis	0.00713	0.00713	CcSEcCtD
Emedastine—Skin disorder—Cladribine—multiple sclerosis	0.0071	0.0071	CcSEcCtD
Emedastine—Sinusitis—Mitoxantrone—multiple sclerosis	0.00707	0.00707	CcSEcCtD
Emedastine—Rhinitis—Mitoxantrone—multiple sclerosis	0.00678	0.00678	CcSEcCtD
Emedastine—Pain—Cladribine—multiple sclerosis	0.00625	0.00625	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00616	0.00616	CcSEcCtD
Emedastine—Discomfort—Azathioprine—multiple sclerosis	0.00612	0.00612	CcSEcCtD
Emedastine—Skin disorder—Azathioprine—multiple sclerosis	0.00577	0.00577	CcSEcCtD
Emedastine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00576	0.00576	CcSEcCtD
Emedastine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00555	0.00555	CcSEcCtD
Emedastine—Asthenia—Cladribine—multiple sclerosis	0.00524	0.00524	CcSEcCtD
Emedastine—Pruritus—Cladribine—multiple sclerosis	0.00517	0.00517	CcSEcCtD
Emedastine—Rhinitis—Triamcinolone—multiple sclerosis	0.00511	0.00511	CcSEcCtD
Emedastine—Rhinitis—Methylprednisolone—multiple sclerosis	0.0051	0.0051	CcSEcCtD
Emedastine—Discomfort—Mitoxantrone—multiple sclerosis	0.00495	0.00495	CcSEcCtD
Emedastine—Eye disorder—Methylprednisolone—multiple sclerosis	0.00476	0.00476	CcSEcCtD
Emedastine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00472	0.00472	CcSEcCtD
Emedastine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00469	0.00469	CcSEcCtD
Emedastine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00467	0.00467	CcSEcCtD
Emedastine—Rash—Cladribine—multiple sclerosis	0.00461	0.00461	CcSEcCtD
Emedastine—Dermatitis—Cladribine—multiple sclerosis	0.0046	0.0046	CcSEcCtD
Emedastine—Headache—Cladribine—multiple sclerosis	0.00458	0.00458	CcSEcCtD
Emedastine—Vision blurred—Prednisolone—multiple sclerosis	0.00455	0.00455	CcSEcCtD
Emedastine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00446	0.00446	CcSEcCtD
Emedastine—Dysgeusia—Triamcinolone—multiple sclerosis	0.00435	0.00435	CcSEcCtD
Emedastine—Eye disorder—Betamethasone—multiple sclerosis	0.00433	0.00433	CcSEcCtD
Emedastine—Eye disorder—Dexamethasone—multiple sclerosis	0.00433	0.00433	CcSEcCtD
Emedastine—Pain—Mitoxantrone—multiple sclerosis	0.00411	0.00411	CcSEcCtD
Emedastine—Discomfort—Prednisolone—multiple sclerosis	0.00406	0.00406	CcSEcCtD
Emedastine—Tachycardia—Prednisolone—multiple sclerosis	0.00385	0.00385	CcSEcCtD
Emedastine—Eye disorder—Prednisone—multiple sclerosis	0.00377	0.00377	CcSEcCtD
Emedastine—Rash—Azathioprine—multiple sclerosis	0.00375	0.00375	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00375	0.00375	CcSEcCtD
Emedastine—Dermatitis—Azathioprine—multiple sclerosis	0.00374	0.00374	CcSEcCtD
Emedastine—Discomfort—Triamcinolone—multiple sclerosis	0.00374	0.00374	CcSEcCtD
Emedastine—Discomfort—Methylprednisolone—multiple sclerosis	0.00373	0.00373	CcSEcCtD
Emedastine—Headache—Azathioprine—multiple sclerosis	0.00372	0.00372	CcSEcCtD
Emedastine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00355	0.00355	CcSEcCtD
Emedastine—Tachycardia—Triamcinolone—multiple sclerosis	0.00354	0.00354	CcSEcCtD
Emedastine—Mental disorder—Prednisone—multiple sclerosis	0.00353	0.00353	CcSEcCtD
Emedastine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00353	0.00353	CcSEcCtD
Emedastine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00351	0.00351	CcSEcCtD
Emedastine—Asthenia—Mitoxantrone—multiple sclerosis	0.00345	0.00345	CcSEcCtD
Emedastine—Discomfort—Dexamethasone—multiple sclerosis	0.00339	0.00339	CcSEcCtD
Emedastine—Discomfort—Betamethasone—multiple sclerosis	0.00339	0.00339	CcSEcCtD
Emedastine—Pain—Prednisolone—multiple sclerosis	0.00337	0.00337	CcSEcCtD
Emedastine—Vision blurred—Prednisone—multiple sclerosis	0.00331	0.00331	CcSEcCtD
Emedastine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00322	0.00322	CcSEcCtD
Emedastine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00322	0.00322	CcSEcCtD
Emedastine—Tachycardia—Dexamethasone—multiple sclerosis	0.00321	0.00321	CcSEcCtD
Emedastine—Tachycardia—Betamethasone—multiple sclerosis	0.00321	0.00321	CcSEcCtD
Emedastine—Eye disorder—Methotrexate—multiple sclerosis	0.00315	0.00315	CcSEcCtD
Emedastine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00313	0.00313	CcSEcCtD
Emedastine—Pain—Triamcinolone—multiple sclerosis	0.0031	0.0031	CcSEcCtD
Emedastine—Rash—Mitoxantrone—multiple sclerosis	0.00303	0.00303	CcSEcCtD
Emedastine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00303	0.00303	CcSEcCtD
Emedastine—Headache—Mitoxantrone—multiple sclerosis	0.00301	0.00301	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00297	0.00297	CcSEcCtD
Emedastine—Discomfort—Prednisone—multiple sclerosis	0.00295	0.00295	CcSEcCtD
Emedastine—Mental disorder—Methotrexate—multiple sclerosis	0.00295	0.00295	CcSEcCtD
Emedastine—Dysgeusia—Methotrexate—multiple sclerosis	0.00287	0.00287	CcSEcCtD
Emedastine—Pain—Dexamethasone—multiple sclerosis	0.00281	0.00281	CcSEcCtD
Emedastine—Pain—Betamethasone—multiple sclerosis	0.00281	0.00281	CcSEcCtD
Emedastine—Nervous system disorder—Prednisone—multiple sclerosis	0.00281	0.00281	CcSEcCtD
Emedastine—Tachycardia—Prednisone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Emedastine—Skin disorder—Prednisone—multiple sclerosis	0.00278	0.00278	CcSEcCtD
Emedastine—Vision blurred—Methotrexate—multiple sclerosis	0.00276	0.00276	CcSEcCtD
Emedastine—Asthenia—Triamcinolone—multiple sclerosis	0.0026	0.0026	CcSEcCtD
Emedastine—Asthenia—Methylprednisolone—multiple sclerosis	0.00259	0.00259	CcSEcCtD
Emedastine—Pruritus—Triamcinolone—multiple sclerosis	0.00256	0.00256	CcSEcCtD
Emedastine—Pruritus—Methylprednisolone—multiple sclerosis	0.00256	0.00256	CcSEcCtD
Emedastine—Rash—Prednisolone—multiple sclerosis	0.00248	0.00248	CcSEcCtD
Emedastine—Dermatitis—Prednisolone—multiple sclerosis	0.00248	0.00248	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00248	0.00248	CcSEcCtD
Emedastine—Headache—Prednisolone—multiple sclerosis	0.00247	0.00247	CcSEcCtD
Emedastine—Discomfort—Methotrexate—multiple sclerosis	0.00247	0.00247	CcSEcCtD
Emedastine—Asthenia—Dexamethasone—multiple sclerosis	0.00236	0.00236	CcSEcCtD
Emedastine—Asthenia—Betamethasone—multiple sclerosis	0.00236	0.00236	CcSEcCtD
Emedastine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00235	0.00235	CcSEcCtD
Emedastine—Pruritus—Betamethasone—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Emedastine—Pruritus—Dexamethasone—multiple sclerosis	0.00233	0.00233	CcSEcCtD
Emedastine—Skin disorder—Methotrexate—multiple sclerosis	0.00232	0.00232	CcSEcCtD
Emedastine—Rash—Triamcinolone—multiple sclerosis	0.00229	0.00229	CcSEcCtD
Emedastine—Dermatitis—Triamcinolone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Emedastine—Rash—Methylprednisolone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Emedastine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Emedastine—Headache—Triamcinolone—multiple sclerosis	0.00227	0.00227	CcSEcCtD
Emedastine—Headache—Methylprednisolone—multiple sclerosis	0.00227	0.00227	CcSEcCtD
Emedastine—Rash—Dexamethasone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Emedastine—Rash—Betamethasone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Emedastine—Dermatitis—Dexamethasone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Emedastine—Dermatitis—Betamethasone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Emedastine—Headache—Betamethasone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Emedastine—Headache—Dexamethasone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Emedastine—Asthenia—Prednisone—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Emedastine—Pain—Methotrexate—multiple sclerosis	0.00205	0.00205	CcSEcCtD
Emedastine—Pruritus—Prednisone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Emedastine—Rash—Prednisone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Emedastine—Dermatitis—Prednisone—multiple sclerosis	0.0018	0.0018	CcSEcCtD
Emedastine—Headache—Prednisone—multiple sclerosis	0.00179	0.00179	CcSEcCtD
Emedastine—Asthenia—Methotrexate—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Emedastine—Pruritus—Methotrexate—multiple sclerosis	0.00169	0.00169	CcSEcCtD
Emedastine—Rash—Methotrexate—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Emedastine—Dermatitis—Methotrexate—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Emedastine—Headache—Methotrexate—multiple sclerosis	0.0015	0.0015	CcSEcCtD
